Rui Fang

机构：Shandong University of Traditional Chinese Medicine, Nanjing University of Science and Technology

发表论文 2 篇

代表论文

• Regulation of adipocyte metabolism: molecular mechanisms and pharmacological potential (2026 · Biochemical Pharmacology)
• A first-in-class orally available DC-SIGN agonist octaparin alleviates TNBS-induced colitis by preserving gut barrier integrity (2026 · Biochemical Pharmacology)